A Phase 1, Multicenter, Open-label Study to Determine the Safety and Pharmacokinetics of MMX Mesalamine Following Administration in Children and Adolescents With Ulcerative Colitis
Phase of Trial: Phase I
Latest Information Update: 15 Apr 2016
At a glance
- Drugs Mesalazine (Primary)
- Indications Ulcerative colitis
- Focus Pharmacokinetics
- Sponsors Shire
- 05 Apr 2013 New source identified and integrated (United Kingdom Clinical Research Network; 12598).
- 12 Jan 2013 Planned number of patients changed from 30 to 64 as reported by European Clinical Trials Database.
- 12 Jan 2013 New source identified and integrated (EudraCT2011-000164-10: European Clinical Trials Database).